1Call KM, Glaser T, Ito CY, et al. Housman DE: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 1990,60, 509-520.
2Lee SB, Haber DA, et al. Wilms tumor and the WT1 gene. Exp cell Res, 2001,264(1),74-99.
3Schamhorst V, van der Eb AJ, Jochemsen AG. WT1 proteins: functions in growth and differectiation. Gene, 2001,273,141-161.
4Menke AL, Schedl A. WT1 and glomerular function. Semin Cell Dev Biol, 2003,14(4),233-40.
5Mrowka C, Schedl A, et al. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features. J Am Soc Nephrol,2000,11 Suppl 16,S106-15.
6Lee S, Huang K, Palmer R,et al. The Wilms'tumor. suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell, 1999,98,663-673.
7Cook DM, Hinkes, MT, Bernfield M. Transcriptional activation of the syndecan-1 promoter by the Wilms'tumor. protein WT1. Oncogene, 1996,13,1789-1799.
8Pated CE, Fleming S, Miles CG, et al. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis. Hum Mol Genet,2002,12(18),2379-94.
9Saylam K, Simon P,et al. WT1 gene mutation responsible for male sex reversal and renal failure: the Frasier syndrome. Eur J Obstet Gynecol Reprod Biol, 2003,110(1):111-3.
10Guo JK, Menke AL, Gubler MC, et al. WT1 is a key regulator of podocyte function:reduced expression levels cause crescentic glomerulaonephritis and mesangial sclerosis. Hum Mol Genet,2002,11,651-659.
2Baudry D, Hamelin M, Cabanis MO, et al. WTI splicing alterations in Wilms' tumors[J]. Clin Cancer Res,2000, 6(10):3957-65.
3Menke A, Mcinnes L, Hastie ND, et al. The Wilms'tumor suppressor WT1 Approaches to gene function [J].Kidney Int, 1998, 53(6):1512-8.
4Coppes M J, Campbell CE, Williams BR. The role of WT1 in Wilms tumorigenesis[J]. FASEB J, 1993, 7(10):886-95.
5Fraizer GC, Wu YJ, Hewitt SM, et al. Transcriptional regulation of the human Wilms' tumor gene (WTI). Cell type-specific enhancer and promiscuous promoter[J]. J Biol Chem, 1994 , 269(12): 8892-900.
6Grubb GR, Yun K, Reeve AE, et al. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour[J]. Oncogene, 1995,10(8): 1677-81.
10Levey AS,Atkins R,Coresh J,et al.Chronic kidney disease as a global public health problem:Approaches and initiatives-a position statement from kidney disease improving global outcomes[J].Kidney Int,2007,72(3):247-259.
